Arcutis Biotherapeutics, Inc.·4

Nov 10, 5:42 PM ET

Edwards Larry Todd 4

4 · Arcutis Biotherapeutics, Inc. · Filed Nov 10, 2025

Insider Transaction Report

Form 4
Period: 2025-11-06
Transactions
  • Sale

    Common Stock

    2025-11-06$25.16/sh29,131$732,927150,193 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.2600, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Documents

1 file
  • 4
    wk-form4_1762814533.xmlPrimary

    FORM 4